SLB · Slb Limited/Nv · Insider Trading

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2026.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

Pursuant to SLB 2004 Stock and Deferral Plan for Non-Employee Directors.

This transaction was executed in multiple trades at prices ranging from $56.01 to $56.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Pursuant to SLB 2004 Stock and Deferral Plan for Non-Employee Directors.

Pursuant to SLB 2004 Stock and Deferral Plan for Non-Employee Directors.

Pursuant to Schlumberger Limited 2004 Stock and Deferral Plan for Non-Employee Directors.

This transaction was executed in multiple trades at prices ranging from $56.13 to $56.235. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Pursuant to SLB 2004 Stock and Deferral Plan for Non-Employee Directors.

This option became fully exercisable on January 15, 2025.

Pursuant to Schlumberger Limited 2004 Stock and Deferral Plan for Non-Employee Directors.

This option became fully exercisable on January 16, 2024.

Pursuant to SLB 2004 Stock and Deferral Plan for Non-Employee Directors.

Pursuant to SLB 2004 Stock and Deferral Plan for Non-Employee Directors.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The Company granted performance share units ("PSUs") to the reporting person on January 18, 2023. Vesting of the PSUs was based on three-year Company performance relative to select key competitors. Most of these competitors had not reported their 2025 audited financial results when the Company's compensation committee met in January 2026 to certify performance under the PSUs. As a result, the Company's compensation committee approved the issuance of 80% of the shares that the committee determined had been earned according to the information available to the committee at the time. As of March 13, 2026, all such competitors had reported their 2025 audited financial results. Shares of common stock reported hereunder represent shares finally determined to have been earned under the PSUs.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

This transaction was executed in multiple trades at prices ranging from $49.70 to $49.705. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares of common stock issued to the reporting person on January 23, 2026 upon achievement of the performance criteria and vesting of performance share units granted on January 18, 2023.

Shares of common stock issued to the reporting person on January 23, 2026 upon achievement of the performance criteria and vesting of performance share units granted on January 18, 2023.